214 related articles for article (PubMed ID: 18650491)
1. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?
Dolk H; Jentink J; Loane M; Morris J; de Jong-van den Berg LT;
Neurology; 2008 Sep; 71(10):714-22. PubMed ID: 18650491
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies.
Dolk H; Wang H; Loane M; Morris J; Garne E; Addor MC; Arriola L; Bakker M; Barisic I; Doray B; Gatt M; Kallen K; Khoshnood B; Klungsoyr K; Lahesmaa-Korpinen AM; Latos-Bielenska A; Mejnartowicz JP; Nelen V; Neville A; O'Mahony M; Pierini A; Rißmann A; Tucker D; Wellesley D; Wiesel A; de Jong-van den Berg LT
Neurology; 2016 May; 86(18):1716-25. PubMed ID: 27053714
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid monotherapy in pregnancy and major congenital malformations.
Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results on pregnancy outcomes in women using lamotrigine.
Tennis P; Eldridge RR;
Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730
[TBL] [Abstract][Full Text] [Related]
5. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiology of orofacial clefts (1995-2006) in France (Congenital Malformations of Alsace Registry)].
Doray B; Badila-Timbolschi D; Schaefer E; Fattori D; Monga B; Dott B; Favre R; Kohler M; Nisand I; Viville B; Kauffmann I; Bruant-Rodier C; Grollemund B; Rinkenbach R; Astruc D; Gasser B; Lindner V; Marcellin L; Flori E; Girard-Lemaire F; Dollfus H
Arch Pediatr; 2012 Oct; 19(10):1021-9. PubMed ID: 22925539
[TBL] [Abstract][Full Text] [Related]
7. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy.
Holmes LB; Baldwin EJ; Smith CR; Habecker E; Glassman L; Wong SL; Wyszynski DF
Neurology; 2008 May; 70(22 Pt 2):2152-8. PubMed ID: 18448870
[TBL] [Abstract][Full Text] [Related]
8. The contribution of maternal epilepsy and its treatment to the etiology of oral clefts: a population based case-control study.
Abrishamchian AR; Khoury MJ; Calle EE
Genet Epidemiol; 1994; 11(4):343-51. PubMed ID: 7813896
[TBL] [Abstract][Full Text] [Related]
9. Maternal use of antibiotics and the risk of orofacial clefts: a nationwide cohort study.
Mølgaard-Nielsen D; Hviid A
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):246-53. PubMed ID: 22125260
[TBL] [Abstract][Full Text] [Related]
10. Comparative safety of antiepileptic drugs during pregnancy.
Hernández-Díaz S; Smith CR; Shen A; Mittendorf R; Hauser WA; Yerby M; Holmes LB; ;
Neurology; 2012 May; 78(21):1692-9. PubMed ID: 22551726
[TBL] [Abstract][Full Text] [Related]
11. Maternal reproductive history and the risk of isolated congenital malformations.
Materna-Kiryluk A; Więckowska B; Wiśniewska K; Borszewska-Kornacka MK; Godula-Stuglik U; Limon J; Rusin J; Sawulicka-Oleszczuk H; Szwałkiewicz-Warowicka E; Walczak M;
Paediatr Perinat Epidemiol; 2011 Mar; 25(2):135-43. PubMed ID: 21281326
[TBL] [Abstract][Full Text] [Related]
12. Final results from 18 years of the International Lamotrigine Pregnancy Registry.
Cunnington MC; Weil JG; Messenheimer JA; Ferber S; Yerby M; Tennis P
Neurology; 2011 May; 76(21):1817-23. PubMed ID: 21606453
[TBL] [Abstract][Full Text] [Related]
13. The teratogenic risk of antiepileptic drug polytherapy.
Vajda FJ; Hitchcock AA; Graham J; O'Brien TJ; Lander CM; Eadie MJ
Epilepsia; 2010 May; 51(5):805-10. PubMed ID: 19817810
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
[TBL] [Abstract][Full Text] [Related]
15. Antiepileptic drug regimens and major congenital abnormalities in the offspring.
Samrén EB; van Duijn CM; Christiaens GC; Hofman A; Lindhout D
Ann Neurol; 1999 Nov; 46(5):739-46. PubMed ID: 10553991
[TBL] [Abstract][Full Text] [Related]
16. Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study.
Garne E; Hansen AV; Morris J; Zaupper L; Addor MC; Barisic I; Gatt M; Lelong N; Klungsøyr K; O'Mahony M; Nelen V; Neville AJ; Pierini A; Tucker D; de Walle H; Wiesel A; Loane M; Dolk H
J Allergy Clin Immunol; 2015 Dec; 136(6):1496-1502.e7. PubMed ID: 26220526
[TBL] [Abstract][Full Text] [Related]
17. Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP.
Tomson T; Battino D; Bonizzoni E; Craig JJ; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Aug; 85(7):580-8. PubMed ID: 26187231
[TBL] [Abstract][Full Text] [Related]
18. Maternal drug use and infant cleft lip/palate with special reference to corticoids.
Källén B
Cleft Palate Craniofac J; 2003 Nov; 40(6):624-8. PubMed ID: 14577813
[TBL] [Abstract][Full Text] [Related]
19. Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register.
Vajda FJ; Graham JE; Hitchcock AA; O'Brien TJ; Lander CM; Eadie MJ
Seizure; 2010 Nov; 19(9):558-61. PubMed ID: 20739196
[TBL] [Abstract][Full Text] [Related]
20. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.
Jentink J; Dolk H; Loane MA; Morris JK; Wellesley D; Garne E; de Jong-van den Berg L;
BMJ; 2010 Dec; 341():c6581. PubMed ID: 21127116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
